Midodrine Dosing and Administration Guidelines

Standard Dosing for Orthostatic Hypotension

The American Diabetes Association recommends starting midodrine at 10 mg three times daily and avoiding doses within several hours of bedtime to minimize supine hypertension, which occurs in up to 25% of patients 1

In hemodialysis patients, midodrine is effectively cleared during dialysis, reducing its half-life to 1.4 hours 1

Start midodrine at 7.5 mg orally three times daily and titrate upward to 12.5 mg three times daily for hepatorenal syndrome-acute kidney injury (HRS-AKI) in cirrhosis patients 2
Always combine midodrine with octreotide (starting at 100 mcg subcutaneously three times daily, titrating to 200 mcg three times daily) for HRS-AKI 2
The American Association for the Study of Liver Diseases notes that the combination of midodrine and octreotide has much lower efficacy than terlipressin for HRS-AKI 4
This combination is inferior to terlipressin for HRS-AKI but can be safely used in a non-monitored setting 3

Administer 5-10 mg of midodrine orally 30 minutes before initiating hemodialysis to prevent intradialytic hypotension 1
Critical timing: midodrine must be given within 30 minutes of hemodialysis initiation to maximize hemodynamic benefit 1
However, observational data shows that midodrine use in dialysis patients was associated with significantly higher risks of cardiovascular events, all-cause hospitalization, and mortality compared to matched non-users 5

The American Heart Association recommends monitoring blood pressure in both supine and standing positions 6
The American College of Cardiology recommends monitoring bradycardia as a primary cardiovascular parameter 6
Monitor for bradycardia, which occurs due to reflex vagal stimulation from increased peripheral vascular resistance 1

Beta-blockers and non-dihydropyridine calcium channel blockers require cautious co-administration with midodrine due to enhanced bradycardia risk 1

Sleep with the head of bed elevated at 10 degrees to prevent nocturnal polyuria and ameliorate nocturnal hypertension 1
Consider ambulatory blood pressure monitoring to identify abnormal diurnal patterns 1

Do not use midodrine for uncomplicated ascites, after large-volume paracentesis, or in spontaneous bacterial peritonitis, as evidence is insufficient and may increase acute kidney injury risk 5

The American Diabetes Association recommends midodrine as a first-line drug for symptomatic orthostatic hypotension with Level A evidence 1